Research progress on tumor whole-cell vaccines prepared with nanoparticles for tumor immunotherapy

被引:3
作者
Mao, Weihong [1 ]
Jia, Sheng [2 ,3 ]
Chen, Ping [2 ,3 ]
机构
[1] Nantong Univ, Peoples Hosp Danyang, Affiliated Danyang Hosp, Danyang 212300, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Affiliated Huaian Hosp, 62 Huaihai Rd S, Huaian 223002, Peoples R China
[3] Second Peoples Hosp Huaian, 62 Huaihai Rd S, Huaian 223002, Peoples R China
关键词
Tumor vaccine; Tumor heterogeneity; Lymph nodes; Cascade effect; Nanostructures; Nanomedicine; CANCER; ACID;
D O I
10.1007/s11051-023-05792-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Tumor vaccines are a promising approach to activate patient's own immune system to fight against tumor. Traditional tumor vaccines utilize tumor cells or tumor antigens to induce specific anti-tumor immune responses, inhibit tumor growth, and achieve the goal of tumor clearance. However, the currently developed tumor antigens are limited to identifying new antigens and focusing on stimulating or intervening in a designated target, which cannot achieve the cascade effect of tumor immunotherapy and leads to poor treatment outcomes. Therefore, an ideal tumor vaccine should effectively solve the problem of tumor heterogeneity and deliver tumor antigens to lymph nodes, promoting antigen uptake and presentation by antigen-presenting cells to stimulate T cell activation. In recent years, tumor whole-cell vaccines prepared by nanotechnology have emerged as a promising approach to transform the entire tumor into personalized tumor antigens without identifying and separating new antigens. These vaccines can achieve the cascade effect of tumor immunotherapy, effectively activating the patient's own immune system. This paper aims to summarize and review the latest research progress on tumor whole-cell vaccines designed based on nanotechnology. The focus is on targeting key nodes in the process of tumor immunotherapy and gradually initiating these important nodes to achieve the cascade effect of tumor immunotherapy, thereby inhibiting tumor recurrence and metastasis.
引用
收藏
页数:11
相关论文
共 50 条
[41]   Research progress on the prevention of tumor by fungal polysaccharides [J].
Yu, Wenbin ;
Zhang, Yufei ;
Yao, Lihua ;
Peng, Jiahua ;
Tu, Yayi ;
He, Bin .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2024, 147
[42]   Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells [J].
Yang, Yuchuan ;
Huangfu, Linkuan ;
Li, Huizhen ;
Yang, Daoke .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2023, 40 (01)
[43]   Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid [J].
Pai, Chien-Chun ;
Kuo, Tzong-Fu ;
Mao, Simon J. T. ;
Chuang, Tien-Fu ;
Lin, Chen-Si ;
Chu, Rea-Min .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2011, 139 (2-4) :187-199
[44]   Research progress on the 'all-in-one' photothermal platform prepared based on polydopamine for tumor synergy therapy [J].
Wang, Li ;
Zhang, Lei .
POLYMER BULLETIN, 2025, 82 (02) :375-395
[45]   Menthol nanoliposomes enhanced anti-tumor immunotherapy by increasing lymph node homing of dendritic cell vaccines [J].
Li, Xianqiang ;
Wu, Yue ;
Wang, Sixue ;
Liu, Jun ;
Zhang, Tingting ;
Wei, Yimei ;
Zhu, Lili ;
Bai, Wei ;
Ye, Tiantian ;
Wang, Shujun .
CLINICAL IMMUNOLOGY, 2022, 244
[46]   Tumor microenvironment-activated polypeptide nanoparticles for oncolytic immunotherapy [J].
Guo, Zhihui ;
Huang, Tianze ;
Lv, Xueli ;
Yin, Renyong ;
Wan, Pengqi ;
Li, Gao ;
Zhang, Peng ;
Xiao, Chunsheng ;
Chen, Xuesi .
BIOMATERIALS, 2025, 314
[47]   Polymeric nanoparticles enable reversing macrophage in tumor microenvironment for immunotherapy [J].
Wang Y. ;
Lin Y.-X. ;
Qiao S.-L. ;
An H.-W. ;
Ma Y. ;
Qiao Z.-Y. ;
Rajapaksha R.P.Y.J. ;
Wang H. .
Wang, Hao (wanghao@nanoctr.cn), 1600, Elsevier Ltd (112) :153-163
[48]   Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN [J].
Geary, S. M. ;
Lemke, C. D. ;
Lubaroff, D. M. ;
Salem, A. K. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (09) :1309-1317
[49]   Hematopoietic stem cell transplant as a platform for tumor immunotherapy [J].
Fuchs, EJ ;
Whartenby, KA .
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (01) :48-53
[50]   Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy [J].
Coleman, Michael F. ;
Cozzo, Alyssa J. ;
Pfeil, Alexander J. ;
Etigunta, Suhas K. ;
Hursting, Stephen D. .
CANCERS, 2020, 12 (04)